An off-the-shelf T-cell receptor therapy has shown promising early results in multiple solid tumor types, according to initial data from a phase 1 dose-escalation trial presented at ESMO Congress.
2022
Doctor Provides Overview on Assessing Vitiligo at EADV 2022
Medical experts use common set of criteria to diagnose disease.
New cell-based therapy for melanoma more effective than existing treatment, trial finds
European researchers announced Saturday that a new treatment for advanced melanoma was more effective than the leading existing therapy in a Phase 3 clinical trial.
Could antibiotics worsen melanoma? Mouse study finds clue in gut microbiome
Researchers investigated melanoma-induced tumor growth in the bones of mice treated with gut microbiome-depleting antibiotics.